In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Ozempic Is About to Go Generic in India, China and Canada
Originally reported by New York Times
Related Articles
Beekeeper jailed after releasing insects on authorities trying to evict her friend
Rebecca Woods, a beekeeper jailed for six months after court heard she admitted to trying to save her friend from evict...
WHCA dinner shooter charged. And, Charles III to address Congress
LISTEN & FOLLOW NPR App Apple Podcasts Spotify Amazon Music iHeart Radio YouTube Music RSS link WHCA d...
Amnesty calls for US strike on Yemen to be investigated as war crime
xwhatsapp-strokecopylinkgoogleAdd Al Jazeera on GoogleinfoRescuers stand at the site of a strike at a detention centre f...
How the US-Israeli war is collapsing the sanctions regime on Iran
xwhatsapp-strokecopylinkgoogleAdd Al Jazeera on GoogleinfoPeople walk in Tehran Bazaar, amid a ceasefire between US and ...